These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3441327)
1. Strontium kinetics in metastasized prostatic carcinoma: a comparison with the predictions of impulse response function analysis. Blake GM; Zivanovic MA; Gray JM Nucl Med Commun; 1987 Nov; 8(11):909-19. PubMed ID: 3441327 [TBL] [Abstract][Full Text] [Related]
9. Palliation of multiple bone metastases from prostatic carcinoma with strontium-89. Tennvall J; Darte L; Lundgren R; el Hassan AM Acta Oncol; 1988; 27(4):365-9. PubMed ID: 2462438 [TBL] [Abstract][Full Text] [Related]
10. Influence of human biokinetics of strontium on internal ingestion dose of 90Sr and absorbed dose of 89Sr to organs and metastases. Li WB; Höllriegl V; Roth P; Oeh U Radiat Environ Biophys; 2008 Apr; 47(2):225-39. PubMed ID: 18204850 [TBL] [Abstract][Full Text] [Related]
11. Strontium 89 therapy for the palliation of pain due to osseous metastases. Robinson RG; Preston DF; Schiefelbein M; Baxter KG JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352 [TBL] [Abstract][Full Text] [Related]
12. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group. Brundage MD; Crook JM; Lukka H Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768 [TBL] [Abstract][Full Text] [Related]
13. Selective accumulation of strontium-89 in metastatic deposits in bone: radio-histological correlation. Ben-Josef E; Lucas DR; Vasan S; Porter AT Nucl Med Commun; 1995 Jun; 16(6):457-63. PubMed ID: 7545802 [TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic bone pain with strontium-89. Robinson RG; Spicer JA; Preston DF; Wegst AV; Martin NL Int J Rad Appl Instrum B; 1987; 14(3):219-22. PubMed ID: 3667305 [TBL] [Abstract][Full Text] [Related]
15. Strontium-89 therapy: strontium kinetics and dosimetry in two patients treated for metastasising osteosarcoma. Blake GM; Zivanovic MA; McEwan AJ; Condon BR; Ackery DM Br J Radiol; 1987 Mar; 60(711):253-9. PubMed ID: 3471288 [TBL] [Abstract][Full Text] [Related]
16. Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma. Buchali K; Correns HJ; Schuerer M; Schnorr D; Lips H; Sydow K Eur J Nucl Med; 1988; 14(7-8):349-51. PubMed ID: 2460352 [TBL] [Abstract][Full Text] [Related]
18. Strontium 89 therapy and relief of pain in patients with prostatic carcinoma metastatic to bone: a dose response relationship? Mertens WC; Stitt L; Porter AT Am J Clin Oncol; 1993 Jun; 16(3):238-42. PubMed ID: 7687818 [TBL] [Abstract][Full Text] [Related]
19. Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89? Dearnaley DP; Bayly RJ; A'Hern RP; Gadd J; Zivanovic MM; Lewington VJ Clin Oncol (R Coll Radiol); 1992 Mar; 4(2):101-7. PubMed ID: 1372817 [TBL] [Abstract][Full Text] [Related]
20. Disseminated intravascular coagulation in a patient treated with strontium-89 for metastatic carcinoma of the prostate. Paszkowski AL; Hewitt DJ; Taylor A Clin Nucl Med; 1999 Nov; 24(11):852-4. PubMed ID: 10551466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]